Keith Woods serves as Executive at X4 Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Keith Woods has executed 5 insider transactions totaling $715.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 12,050 shares valued at $0.
Keith Woods currently holds 12,050 shares of X4 Pharmaceuticals, Inc (XFOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith Woods has been a net seller of XFOR stock. They have purchased $0 and sold $715.1K worth of shares.
Keith Woods's most recent insider trade was on Feb 20, 2026, when they sold 12,050 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 13, 2026 | SRRK | $715.1K | Sale | 16,746 | $42.70 | Discretionary |
| Jun 10, 2024 | XFOR | $0 | Award | 45,000 | $N/A | Discretionary |
| Oct 16, 2023 | XFOR | $0 | Award | 90,000 | $N/A | Discretionary |